Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Neoplasms 2 Melanoma 2 Carcinoma, Hepatocellular 2 Squamous Cell Carcinoma of Head and Neck 1 Solid Tumor 1 Prostatic Neoplasms 1 Pancreatic Neoplasms 1 Neoplasms by Site 1 Neoplasms by Histologic Type 1 Myelodysplastic Syndromes 1 Hematologic Neoplasms 1 Cytopenia 1 Coronavirus Infections 1 Colonic Neoplasms 1 Carcinoma, Non-Small-Cell Lung 1 COVID-19 1

Interventions

Fluorouracil 219 Leucovorin 202 Oxaliplatin 192 Irinotecan 150 Bevacizumab 110 Capecitabine 94 Cetuximab 90 Folfox protocol 54 Chemotherapy, Adjuvant 36 Panitumumab 30 Colonoscopy 30 pembrolizumab 23 Drug Therapy 23 Nivolumab 22 Magnetic Resonance Spectroscopy 22 Gemcitabine 21 Blood Specimen Collection 20 Radiotherapy 19 Floxuridine 19 Biopsy 19 Neoadjuvant Therapy 18 Laparoscopy 18 IFL protocol 18 Early Intervention, Educational 18 Celecoxib 18 Surveys and Questionnaires 17 Surgical Procedures, Operative 16 Immunohistochemistry 16 Exercise 16 trifluridine tipiracil drug combination 14

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Colonic Neoplasms × HuMax-IL8 × Clear all

NCT03026140 2026-03-05

NICHE

The Netherlands Cancer Institute

Phase 2 Recruiting

Gastrointestinal

Colonic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡